Institutional shares held 136 Million
348K calls
250K puts
Total value of holdings $4.86B
$12.4M calls
$8.92M puts
Market Cap $2.12B
59,315,100 Shares Out.
Institutional ownership 229.34%
# of Institutions 341


Latest Institutional Activity in PCVX

Top Purchases

Q2 2025
Banque Pictet & Cie Sa Shares Held: 83.4K ($2.98M)
Q2 2025
Harbor Capital Advisors, Inc. Shares Held: 102K ($3.66M)
Q2 2025
111 Capital Shares Held: 11K ($393K)
Q2 2025
Gsa Capital Partners LLP Shares Held: 8.8K ($314K)
Q2 2025
Signaturefd, LLC Shares Held: 3.27K ($117K)

Top Sells

Q2 2025
Assenagon Asset Management S.A. Shares Held: 48K ($1.71M)
Q2 2025
Shell Asset Management CO Shares Held: 1.91K ($68.2K)
Q1 2025
Perceptive Advisors LLC Shares Held: 707K ($25.2M)
Q1 2025
Fred Alger Management, LLC Shares Held: 22.4K ($799K)
Q1 2025
Price T Rowe Associates Inc Shares Held: 3.54M ($127M)

About PCVX

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.


Insider Transactions at PCVX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
545K Shares
From 20 Insiders
Grant, award, or other acquisition 153K shares
Exercise of conversion of derivative security 392K shares
Sell / Disposition
490K Shares
From 15 Insiders
Payment of exercise price or tax liability 53.3K shares
Bona fide gift 77.3K shares
Open market or private sale 360K shares

Track Institutional and Insider Activities on PCVX

Follow Vaxcyte, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX